Quantitative analysis of Ki67 positive cells in whole brain slices harvested at various timepoints demonstrated increasing tumour cell burden up to 20 weeks after injection (Fig. 1B, supplementary Fig. S1C). This evidence concerns the gene MKI67 and neoplasm.